fluticasone propionate/salmeterol xinafoate

DRUG2 trials

Sponsors

Dey, GlaxoSmithKline

Conditions

Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic Obstructive

Phase 2

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT00403286

DeyChronic Obstructive Pulmonary Disease

Start: 2006-11-30End: 2007-05-31Updated: 2009-06-30

Unknown Phase

Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population

CompletedNCT01337336

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2010-10-31End: 2011-03-31Updated: 2017-05-30